Calliditas Therapeutics AB (CALT)

NASDAQ: CALT · IEX Real-Time Price · USD
19.45
0.99 (5.36%)
At close: May 20, 2022 4:00 PM
18.70
-0.75 (-3.86%)
After-hours:May 20, 2022 5:05 PM EDT

Income Statement (Trailing)

Millions SEK. Fiscal year is Jan - Dec.
Period Ended2021-12-312021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-31
Revenue
229.350.40.40.8747.0647.06185.3184.83--0
Revenue Growth (YoY)
387.35%-99.15%-99.78%-99.53%-------
Gross Profit
229.350.40.40.8747.0647.06185.3184.83--0
Selling, General & Admin
390.23248.07182.49141.72101.6370.8971.0962.88--31.13
Research & Development
357.49303.98277.34241.37209.09190.39173.19149.83--99.26
Other Operating Expenses
6.09-0.63-1.26-2.5-1.84-4.65-1.360.14002.09
Operating Expenses
753.8551.41458.58380.59308.88256.63242.92212.85--132.48
Operating Income
-524.46-551.01-458.18-379.72-261.82-209.57-57.62-28.02---132.48
Interest Expense / Income
9.2562.1451.0256.9824.96-10.6-3.075.41--0.01
Other Expense / Income
-29.58-8.21-4.98-3.56-0.93-0.93-0.93-0.9300-0.44
Pretax Income
-504.13-604.94-504.22-433.13-285.85-198.05-53.62-32.500-132.05
Income Tax
-3.84-11.19-8.980.360.260.180.120.08--0
Net Income
-500.29-593.75-495.23-433.49-286.11-198.23-53.74-32.58---132.05
Net Income Common
-500.29-593.75-495.23-433.49-286.11-198.23-53.74-32.58---132.05
Shares Outstanding (Basic)
5050504646464646---
EPS (Basic)
-19.68-24.44-21.04-19.32-13.30-10.36-2.64-1.76---10.18
EPS (Diluted)
-19.68-24.44-21.04-19.32-13.30-10.36-2.66-1.76---10.18
Free Cash Flow Per Share
-18.75-19.64-17.00-13.36-10.14-2.08-1.75-3.07---
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%---
Operating Margin
-228.67%-137753.00%-114543.75%-43446.22%-556.36%-445.32%-31.10%-15.16%---
Profit Margin
-218.14%-148437.00%-123808.50%-49598.86%-607.97%-421.23%-29.00%-17.63%---
Free Cash Flow Margin
-204.13%-122619.75%-106146.25%-35375.40%-498.64%-102.50%-21.87%-38.48%---
Effective Tax Rate
0.76%1.85%1.78%-0.08%-0.09%-0.09%-0.21%-0.24%--0.00%
EBITDA
-494.88-542.8-453.2-376.16-260.9-208.64-56.7-27.09---132.04
EBITDA Margin
-215.78%-135700.25%-113299.25%-43038.44%-554.39%-443.36%-30.60%-14.66%---
EBIT
-494.88-542.8-453.2-376.16-260.9-208.64-56.7-27.09---132.04
EBIT Margin
-215.78%-135700.25%-113299.25%-43038.44%-554.39%-443.36%-30.60%-14.66%---
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).